These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37270358)

  • 1. A Restaging Transurethral Resection of Bladder Tumor Is Always Necessary For High-grade T1 Non-muscle-invasive Bladder Cancer.
    Lichtbroun B; Srivastava A; Ghodoussipour S
    Eur Urol Focus; 2023 Jul; 9(4):557-558. PubMed ID: 37270358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Restaging Transurethral Resection of the Bladder Is Always Necessary for High-grade T1 Non-muscle-invasive Bladder Cancer: Con.
    Gontero P; Livoti S; Soria F
    Eur Urol Focus; 2023 Jul; 9(4):559-560. PubMed ID: 37005168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?
    Beijert IJ; Hentschel AE; Bründl J; Compérat EM; Plass K; Rodríguez O; Subiela Henríquez JD; Hernández V; de la Peña E; Alemany I; Turturica D; Pisano F; Soria F; Čapoun O; Bauerová L; Pešl M; Bruins HM; Runneboom W; Herdegen S; Breyer J; Brisuda A; Calatrava A; Rubio-Briones J; Seles M; Mannweiler S; Bosschieter J; Kusuma VRM; Ashabere D; Huebner N; Cotte J; Contieri R; Mertens LS; Claps F; Masson-Lecomte A; Liedberg F; Cohen D; Lunelli L; Cussenot O; El Sheikh S; Volanis D; Côté JF; Rouprêt M; Haitel A; Shariat SF; Mostafid AH; Nieuwenhuijzen JA; Zigeuner R; Dominguez-Escrig JL; Hacek J; Zlotta AR; Burger M; Evert M; Hulsbergen-van de Kaa CA; van der Heijden AG; Kiemeney LALM; Soukup V; Molinaro L; Gontero P; Llorente C; Algaba F; Palou J; N'Dow J; Ribal MJ; van der Kwast TH; Babjuk M; Sylvester RJ; van Rhijn BWG
    Int Urol Nephrol; 2024 Apr; 56(4):1323-1333. PubMed ID: 37980689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical rationale and safety of restaging transurethral resection in indication-stratified patients with high-risk non-muscle-invasive bladder cancer.
    Zapała P; Dybowski B; Poletajew S; Białek Ł; Niewczas A; Radziszewski P
    World J Surg Oncol; 2018 Jan; 16(1):6. PubMed ID: 29334958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of residual tumor at restaging transurethral bladder resection in high-risk non-muscle-invasive bladder cancer.
    Guigui A; Basile G; Zattoni F; Gallioli A; Verri P; Aumatell J; Gondran-Tellier B; Lechevallier E; Bastide C; Uleri A; Sica M; Long-Depaquit T; Dinoi G; Moro FD; Akiki A; Toledano H; Rajwa P; Montorsi F; Amparore D; Porpiglia F; Breda A; Moschini M; Baboudjian M
    World J Urol; 2024 Aug; 42(1):480. PubMed ID: 39133324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of transurethral resection of bladder tumour documentation: implications for non-muscle-invasive bladder cancer risk stratification and management.
    Botros A; Rival PM; Page F; Davis ID; Sengupta S
    BJU Int; 2024 Apr; 133 Suppl 4():7-10. PubMed ID: 38116588
    [No Abstract]   [Full Text] [Related]  

  • 8. Is a restaging TURBT necessary in high-risk NMIBC if the initial TURBT was performed with blue light?
    Alsyouf M; Ladi-Seyedian SS; Konety B; Pohar K; Holzbeierlein JM; Kates M; Willard B; Taylor JM; Liao JC; Kaimakliotis HZ; Porten SP; Steinberg GD; Tyson MD; Lotan Y; Daneshmand S;
    Urol Oncol; 2023 Feb; 41(2):109.e9-109.e14. PubMed ID: 36435710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upstaging after Transurethral Resection of the Bladder for Non-Muscle-Invasive Cancer of the Bladder: Who Is at Highest Risk?
    Volz Y; Trappmann R; Ebner B; Eismann L; Enzinger B; Hermans J; Pyrgidis N; Stief C; Schulz GB
    Urol Int; 2024; 108(1):42-48. PubMed ID: 37944501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review.
    Cumberbatch MGK; Foerster B; Catto JWF; Kamat AM; Kassouf W; Jubber I; Shariat SF; Sylvester RJ; Gontero P
    Eur Urol; 2018 Jun; 73(6):925-933. PubMed ID: 29523366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does repeat transurethral resection of bladder tumor influence the diagnosis and prognosis of T1 bladder cancer? A systematic review and meta-analysis.
    Lin L; Guo X; Ma Y; Zhu J; Li X
    Eur J Surg Oncol; 2023 Jan; 49(1):29-38. PubMed ID: 35752497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Complete Transurethral Resection of Bladder Tumor Using Photodynamic Diagnosis for High-Risk Nonmuscle Invasive Bladder Cancer: Is a Restaging Photodynamic Transurethral Resection Really Necessary?
    Tadrist A; Gondran-Tellier B; McManus R; Al Balushi K; Akiki A; Gaillet S; Delaporte V; Karsenty G; Lechevallier E; Boissier R; Baboudjian M
    J Endourol; 2021 Jul; 35(7):1042-1046. PubMed ID: 33626963
    [No Abstract]   [Full Text] [Related]  

  • 13. Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?
    Herr HW; Donat SM; Dalbagni G
    J Urol; 2007 Jan; 177(1):75-9; discussion 79. PubMed ID: 17162005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transurethral en bloc resection with bipolar button electrode for non-muscle invasive bladder cancer.
    Zhang J; Wang L; Mao S; Liu M; Zhang W; Zhang Z; Guo Y; Huang B; Yan Y; Huang Y; Yao X
    Int Urol Nephrol; 2018 Apr; 50(4):619-623. PubMed ID: 29478198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Restaging Transurethral Resection of Bladder Tumor on Survival Parameters in T1 Nonmuscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis.
    Krajewski W; Nowak Ł; Poletajew S; Tukiendorf A; Moschini M; Mari A; Di Trapani E; Xylinas E; Kiełb P; Wełna M; Zdrojowy R
    J Endourol; 2020 Aug; 34(8):795-804. PubMed ID: 32336149
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of second transurethral resection on recurrence in patients with high-grade Ta bladder cancer.
    Taoka R; Matsuoka Y; Kohashiguchi K; Miura T; Tohi Y; Miyauchi Y; Kato T; Tsunemori H; Ueda N; Kakehi Y; Sugimoto M
    Int J Urol; 2020 Dec; 27(12):1130-1135. PubMed ID: 32985754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Repeat transurethral resection for non-muscle invasive bladder cancer].
    Shen YJ; Ye DW; Yao XD; Zhang SL; Dai B; Zhu YP; Zhang HL; Zhu Y; Shi GH; Ma CG
    Zhonghua Wai Ke Za Zhi; 2009 May; 47(10):725-7. PubMed ID: 19615201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Will repeat resection after initial transurethral en bloc resection benefit patients with high-risk non-muscle-invasive bladder cancer? A propensity score matching analysis.
    Zhou M; Yang B; Zhou S; Yu P; Li F; Liu Z; Hu H
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):5861-5869. PubMed ID: 36585983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeat transurethral resection for non-muscle-invasive bladder cancer: a contemporary series.
    Gendy R; Delprado W; Brenner P; Brooks A; Coombes G; Cozzi P; Nash P; Patel MI
    BJU Int; 2016 Apr; 117 Suppl 4():54-9. PubMed ID: 26486968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Factors for Residual Cancer in Second Transurethral Resection for Non-muscle-invasive Bladder Cancer.
    Akitake M; Yamaguchi A; Shiota M; Imada K; Tatsugami K; Yokomizo A; Naito S; Eto M
    Anticancer Res; 2019 Aug; 39(8):4325-4328. PubMed ID: 31366524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.